United States v. Arnoldo Morfin-Arias ( 2019 )


Menu:
  •      Case: 18-10507       Document: 00514873937         Page: 1     Date Filed: 03/14/2019
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE FIFTH CIRCUIT
    United States Court of Appeals
    Fifth Circuit
    FILED
    No. 18-10507                           March 14, 2019
    Summary Calendar
    Lyle W. Cayce
    Clerk
    UNITED STATES OF AMERICA,
    Plaintiff - Appellee
    v.
    ARNOLDO MORFIN-ARIAS, also known as Efrain Arias, also known as Pollo,
    Defendant - Appellant
    Appeal from the United States District Court
    for the Northern District of Texas
    USDC No. 4:17-CR-194-1
    Before BARKSDALE, ELROD, and HO, Circuit Judges.
    PER CURIAM: *
    Arnoldo Morfin-Arias pleaded guilty to conspiracy to possess, with the
    intent to distribute, methamphetamine, in violation of 21 U.S.C. § 846, and
    was sentenced, inter alia, to life imprisonment. He contends the sentence is
    both procedurally and substantively unreasonable.
    Although post-Booker, the Sentencing Guidelines are advisory only, the
    district court must avoid significant procedural error, such as improperly
    * Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not
    be published and is not precedent except under the limited circumstances set forth in 5th Cir.
    R. 47.5.4.
    Case: 18-10507     Document: 00514873937      Page: 2   Date Filed: 03/14/2019
    No. 18-10507
    calculating the Guidelines sentencing range. Gall v. United States, 
    552 U.S. 38
    , 48–51 (2007). If no such procedural error exists, a properly preserved
    objection to an ultimate sentence is reviewed for substantive reasonableness
    under an abuse-of-discretion standard. 
    Id. at 51;
    United States v. Delgado-
    Martinez, 
    564 F.3d 750
    , 751–53 (5th Cir. 2009). In that respect, for issues
    preserved in district court, its application of the Guidelines is reviewed de novo;
    its factual findings, only for clear error.     E.g., United States v. Cisneros-
    Gutierrez, 
    517 F.3d 751
    , 764 (5th Cir. 2008).
    For procedural error, Morfin presents three bases. First, he asserts the
    court erred in assessing a four-level enhancement for his leadership role,
    pursuant to Guideline § 3B1.1(a).       The enhancement was based on the
    unrebutted facts of the presentence investigation report (PSR), which
    established he: operated at the top of the large drug conspiracy’s hierarchy;
    recruited Cherry into the conspiracy; directed and supervised Hurtado-Cruz in
    drug-dealing activities; trained a new recruit from Mexico; exercised decision-
    making authority regarding not just the logistics and pricing of drug
    transactions, but also regarding the laundering of the proceeds; and, used his
    direct contacts with Mexican cartels to operate as the primary source of supply
    for a significant number of coconspirators. See U.S.S.G. § 3B1.1 cmt. n.4; see
    also United States v. Cooper, 
    274 F.3d 230
    , 247 (5th Cir. 2001); United States
    v. Valencia, 
    44 F.3d 269
    , 273 (5th Cir. 1995). Because the court’s finding that
    Morfin exercised a leadership role is plausible in the light of the record as a
    whole, the court did not clearly err in imposing the four-level enhancement.
    See United States v. Villanueva, 
    408 F.3d 193
    , 204 (5th Cir. 2005); see also
    Anderson v. City of Bessemer City, 
    470 U.S. 564
    , 573–74 (1985).
    For the second of the three claimed procedural errors, Morfin challenges
    the quantity of drugs attributed to him for sentencing purposes. He contests:
    2
    Case: 18-10507    Document: 00514873937      Page: 3   Date Filed: 03/14/2019
    No. 18-10507
    the cocaine found in coconspirator Guerra’s garage; the cocaine and
    methamphetamine listed in paragraphs 24 through 28 of the PSR relating to
    specific drug transactions conducted by Cherry; and, the methamphetamine
    related to drug transactions conducted by Obregon listed in paragraphs 31
    through 33 of the PSR. (By failing to brief his challenge to the other drug
    quantities objected to in district court, he has abandoned those claims. See
    Yohey v. Collins, 
    985 F.2d 222
    , 225 (5th Cir. 1993).)
    The court based its drug-quantity finding on the unrebutted facts of the
    PSR, and Morfin has failed to demonstrate those facts are materially untrue
    or unreliable. United States v. Gomez-Alvarez, 
    781 F.3d 787
    , 796 (5th Cir.
    2015); United States v. Parker, 
    133 F.3d 322
    , 329 (5th Cir. 1998). Therefore,
    he has failed to show the court’s drug-quantity finding was clearly erroneous.
    United States v. Betancourt, 
    422 F.3d 240
    , 246–47 (5th Cir. 2005). (Even were
    that not so, and assuming arguendo the court erred in including any or all of
    the challenged drug quantities, Morfin’s base-offense level of 38 would remain
    unchanged even if the challenged quantities are excluded from the PSR’s drug
    quantity determination, rendering any error harmless.              See U.S.S.G.
    § 2D1.1(c)(1) (drug-quantity table showing base-offense levels); see also United
    States v. Solis, 
    299 F.3d 420
    , 462 (5th Cir. 2002).)
    For the third, and final, claimed procedural error, Morfin contends the
    court erred in its Guidelines calculations because it applied the three-level
    acceptance-of-responsibility reduction to his adjusted-offense level of 46. He
    asserts that, because offense level 43 is the highest level permitted by the
    Guidelines, the district court should have deducted three levels from 43, rather
    than 46.   But, as Morfin concedes, this claim is foreclosed by our court’s
    decision in United States v. Wood, 
    48 F.3d 530
    , No. 94-10217, 
    1995 WL 84100
    ,
    *6–7 (5th Cir. 1995) (unpublished). (Though unpublished, Wood is binding
    3
    Case: 18-10507    Document: 00514873937     Page: 4   Date Filed: 03/14/2019
    No. 18-10507
    precedent because it was issued before January 1, 1996. 5th Cir. R. 47.5.3;
    Zenor v. El Paso Healthcare Sys., Ltd., 
    176 F.3d 847
    , 854 n.4 (5th Cir. 1999).)
    While he suggests Wood was erroneously decided, our court must follow our
    precedent, absent a change in the law, such as en banc reconsideration, or a
    superseding Supreme Court decision. See United States v. Lipscomb, 
    299 F.3d 303
    , 313 n.34 (5th Cir. 2002).
    Finally, for his claimed substantively-unreasonable sentence, Morfin
    maintains the court erred by: assuming, Morfin asserts, a Guidelines sentence
    was presumptively proper; failing to give sufficient weight to certain aspects of
    his history and characteristics; and, failing to balance fairly the relevant
    sentencing factors. At sentencing, the court considered the factors Morfin
    discusses in his appellate brief and found a within-Guidelines sentence was
    appropriate given the 18 U.S.C. § 3553(a) sentencing factors. See 
    Gall, 552 U.S. at 49
    –51.
    Because the court imposed a within-Guidelines sentence, it is
    presumptively reasonable. United States v. Jenkins, 
    712 F.3d 209
    , 214–15 (5th
    Cir. 2013). Morfin points to no failure by the court to account for a factor that
    should have received significant weight, no reliance on an improper factor, and
    no clear error of judgment in balancing the factors.        See 
    id. Morfin is
    essentially asking our court to reweigh the § 3553(a) factors, which we will not
    do. See 
    Gall, 552 U.S. at 51
    .
    AFFIRMED.
    4